Historically, scientists have referred to this compound by various names, including Growth-modulating peptide and Liver growth factor Cu-GHK, reflecting its diverse biological activity throughout the body
Cosmetic Cosmetic Peptide Supplier Explore how Atlas BioLabs supports formulation teams, private-label buyers, and skincare ingredient sourcing conversations
Clinical Status: GHK-Cu is an endogenous copper-binding peptide studied in both animal and human research models for wound healing, skin regeneration, and anti-aging applications
Phase 1: Activation (Weeks 14) Dose: Daily GHK-Cu activates collagen production while its copper component enables proper structural cross-linking BPC-157 builds the network of small blood vessels needed to feed active tissue TB-4 mobilizes and organizes repair cells KPV simultaneously suppresses inflammatory interference Expected: Skin hydration improves, tone evens, texture softens, redness decreases
Are Cerebrolysin and Semax stimulants
Inclusion criteria encompassed all studies employing in vitro models (e.g., fibroblast proliferation, keratinocyte migration, collagen synthesis assays), in vivo studies using animal models for wound healing assessments, clinical trials evaluating the efficacy and safety of tripeptides in human subjects, and studies utilizing molecular, biochemical, or histological analyses to determine the mechanisms of tripeptides in wound recovery
